Form 4: Select Medical Holdings Corp: Chief Information Officer Receives 75,000 Shares of Restricted Stock

Brian R. Rusignuolo, Chief Information Officer of Select Medical Holdings Corp, was granted 75,000 shares of restricted stock on April 30, 2024, which will vest in full on April 30, 2027.

Summary

• Brian R. Rusignuolo, the Chief Information Officer of Select Medical Holdings Corp, reported a transaction on April 30, 2024.
• He acquired 75,000 shares of common stock through a grant of restricted stock.
• The restricted stock was granted at a price of $0 per share.
• These shares will vest in full on April 30, 2027, which is the third anniversary of the grant date.
• Following this transaction, Rusignuolo's total beneficial ownership of Select Medical Holdings Corp common stock is 358,775 shares.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, indicating stability and alignment of interests. The sentiment is neutral to positive.

Positives

• The grant of restricted stock to a key executive aligns their interests with the long-term performance of the company.
• The vesting period of three years suggests a commitment to the company's future.

Future Outlook

The vesting of the restricted stock in 2027 suggests a long-term commitment from the executive.

Industry Context

Grants of restricted stock are a common form of executive compensation in the healthcare industry, aligning management's interests with shareholder value.

Comparison to Industry Standards

• Executive compensation packages, including restricted stock grants, are common in publicly traded healthcare companies like HCA Healthcare, Universal Health Services, and Tenet Healthcare.
• The size and vesting schedule of the grant are likely benchmarked against similar roles and company performance within the industry.

Stakeholder Impact

• Shareholders may view the grant of restricted stock positively, as it incentivizes the CIO to focus on long-term value creation.
• Employees may see this as a positive sign of investment in leadership and the company's future.

Key Dates